Balyasny Asset Management’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $189K | Buy |
12,217
+444
| +4% | +$6.86K | ﹤0.01% | 1818 |
|
|
2025
Q1 | $175K | Sell |
11,773
-181,430
| -94% | -$2.7M | ﹤0.01% | 1838 |
|
|
2024
Q4 | $2.56M | Buy |
+193,203
| New | +$2.56M | ﹤0.01% | 1043 |
|
|
2024
Q2 | – | Sell |
-15,354
| Closed | -$213K | – | 2404 |
|
|
2024
Q1 | $213K | Buy |
+15,354
| New | +$213K | ﹤0.01% | 1762 |
|
|
2023
Q4 | – | Sell |
-21,007
| Closed | -$325K | – | 2258 |
|
|
2023
Q3 | $325K | Sell |
21,007
-12,338
| -37% | -$191K | ﹤0.01% | 1422 |
|
|
2023
Q2 | $524K | Buy |
+33,345
| New | +$524K | ﹤0.01% | 1453 |
|
|
2022
Q4 | – | Sell |
-56,522
| Closed | -$733K | – | 2732 |
|
|
2022
Q3 | $733K | Buy |
56,522
+41,686
| +281% | +$541K | ﹤0.01% | 1484 |
|
|
2022
Q2 | $208K | Buy |
+14,836
| New | +$208K | ﹤0.01% | 1759 |
|
|
2021
Q3 | – | Sell |
-58,677
| Closed | -$988K | – | 2072 |
|
|
2021
Q2 | $988K | Buy |
+58,677
| New | +$988K | ﹤0.01% | 1119 |
|
|
2020
Q2 | – | Sell |
-15,844
| Closed | -$241K | – | 1300 |
|
|
2020
Q1 | $241K | Buy |
+15,844
| New | +$241K | ﹤0.01% | 903 |
|
|
2019
Q2 | – | Sell |
-344,714
| Closed | -$7.02M | – | 1543 |
|
|
2019
Q1 | $7.02M | Buy |
+344,714
| New | +$7.02M | 0.05% | 426 |
|